According to Neurones's latest financial reports the company has S$0.44 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | S$0.43 B | 11.12% |
2022-12-31 | S$0.39 B | -3.64% |
2021-12-31 | S$0.40 B | -6.41% |
2020-12-31 | S$0.43 B | 31.4% |
2019-12-31 | S$0.33 B | 20.75% |
2018-12-31 | S$0.27 B | 10.2% |
2017-12-31 | S$0.24 B | 15.26% |
2016-12-31 | S$0.21 B | 5.95% |
2015-12-31 | S$0.20 B | 2.67% |
2014-12-31 | S$0.19 B | 11.93% |
2013-12-31 | S$0.17 B | 24.41% |
2012-12-31 | S$0.14 B | 11.94% |
2011-12-31 | S$0.12 B | 8.01% |
2010-12-31 | S$0.11 B | -3.3% |
2009-12-31 | S$0.12 B | 11.01% |
2008-12-31 | S$0.10 B | -8.59% |
2007-12-31 | S$0.11 B | 22.3% |
2006-12-31 | S$97.95 M | -1.63% |
2005-12-31 | S$99.58 M | -3.51% |
2004-12-31 | S$0.10 B | 708.15% |
2003-12-31 | S$12.77 M | 55.76% |
2002-12-31 | S$8.19 M |